CN106748950B - 一种布瓦西坦及其中间体的制备方法 - Google Patents
一种布瓦西坦及其中间体的制备方法 Download PDFInfo
- Publication number
- CN106748950B CN106748950B CN201710025130.4A CN201710025130A CN106748950B CN 106748950 B CN106748950 B CN 106748950B CN 201710025130 A CN201710025130 A CN 201710025130A CN 106748950 B CN106748950 B CN 106748950B
- Authority
- CN
- China
- Prior art keywords
- preparation
- solvent
- ratio
- waxitan
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
溶剂与底物体积质量比 | 含量 | 收率 |
4:1 | 75% | 83% |
5:1 | 96.5% | 90% |
6:1 | 97.1% | 80% |
7:1 | 97.4% | 65% |
溶剂 | 纯度 |
乙酸乙酯 | 无固体 |
乙醇 | 无固体 |
乙酸乙丙酯 | 97.8% |
乙醚 | 98% |
异丙醚 | 99.8% |
丙酮 | 无固体 |
还原剂 | B-III(A)含量 | B-III(B)含量 |
氢气 | 32% | 68% |
环己烯 | 28% | 72% |
甲酸铵 | 50% | 50% |
水合肼 | 27% | 73% |
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710025130.4A CN106748950B (zh) | 2017-01-13 | 2017-01-13 | 一种布瓦西坦及其中间体的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710025130.4A CN106748950B (zh) | 2017-01-13 | 2017-01-13 | 一种布瓦西坦及其中间体的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106748950A CN106748950A (zh) | 2017-05-31 |
CN106748950B true CN106748950B (zh) | 2019-09-03 |
Family
ID=58945397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710025130.4A Active CN106748950B (zh) | 2017-01-13 | 2017-01-13 | 一种布瓦西坦及其中间体的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106748950B (zh) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107337628B (zh) | 2017-08-10 | 2022-02-08 | 浙江华海药业股份有限公司 | 一种制备左乙拉西坦的方法 |
CN109593055B (zh) * | 2017-09-30 | 2022-04-26 | 上海医药工业研究院 | 一种布瓦西坦异构体(2s,4s)的制备方法 |
CN108147988B (zh) * | 2018-02-13 | 2020-10-02 | 扬州奥锐特药业有限公司 | 一种高手性纯度内酰胺化合物的制备方法 |
CN108101823A (zh) * | 2018-02-13 | 2018-06-01 | 扬州奥锐特药业有限公司 | 一种高手性纯度内酰胺中间体及布瓦西坦的制备方法 |
CN108548873A (zh) * | 2018-03-20 | 2018-09-18 | 丽珠集团新北江制药股份有限公司 | 一种布瓦西坦中间体异构体的检测方法 |
CN110615744B (zh) | 2018-06-20 | 2023-01-06 | 上海朴颐化学科技有限公司 | 一种布瓦西坦中间体及其制备方法 |
CN109852644B (zh) * | 2018-11-13 | 2023-04-07 | 弈柯莱生物科技(上海)股份有限公司 | 一种制备布瓦西坦中间体的方法 |
CN111333563B (zh) * | 2018-12-19 | 2023-11-07 | 上海科胜药物研发有限公司 | 一种布瓦西坦中间体的制备方法 |
CN109655557A (zh) * | 2019-01-08 | 2019-04-19 | 丽珠集团新北江制药股份有限公司 | 一种布瓦西坦及其杂质的检测方法 |
CN113024434A (zh) * | 2019-12-24 | 2021-06-25 | 上海科胜药物研发有限公司 | 一种布瓦西坦中间体的制备方法 |
CN113045468A (zh) * | 2019-12-26 | 2021-06-29 | 上虞京新药业有限公司 | 一种布瓦西坦中间体的制备方法 |
CN111154735B (zh) * | 2020-01-10 | 2022-02-22 | 宁波酶赛生物工程有限公司 | 一种烯酮还原酶与一种布瓦西坦中间体的制备方法 |
EP4144724A4 (en) | 2020-04-30 | 2023-03-15 | Shanghai Syncores Technologies Inc. Ltd. | BRIVARACETAM AND PROCESS FOR MAKING AN INTERMEDIATE THEREOF |
EP4166540A1 (en) * | 2020-06-15 | 2023-04-19 | Zhejiang Tianyu Pharmaceutical Co., Ltd | Preparation method for brivaracetam |
CN111579706B (zh) * | 2020-07-03 | 2023-04-07 | 宜宾市南溪区红光制药有限公司 | 一种布瓦西坦水解杂质的检测方法 |
CN115010640A (zh) * | 2022-07-13 | 2022-09-06 | 苏州诚和医药化学有限公司 | 一种布瓦西坦的制备工艺 |
CN115028563B (zh) * | 2022-07-15 | 2024-04-09 | 苏州诚和医药化学有限公司 | 一种布瓦西坦中间体的制备方法 |
CN115340482B (zh) * | 2022-08-25 | 2024-05-14 | 四川诺非特生物药业科技有限公司 | 一种布立西坦的合成方法 |
CN115557873A (zh) * | 2022-10-19 | 2023-01-03 | 浙江美诺华药物化学有限公司 | 一种布瓦西坦甲酯化杂质合成方法 |
CN115806519A (zh) * | 2022-12-22 | 2023-03-17 | 浙江普洛家园药业有限公司 | 一种布瓦西坦中间体的拆分方法及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1882535A (zh) * | 2003-09-24 | 2006-12-20 | Ucb股份有限公司 | 2-氧代-1-吡咯烷衍生物的制备方法 |
CN105130879A (zh) * | 2015-07-24 | 2015-12-09 | 沧州那瑞化学科技有限公司 | (R)-3-Boc-氨基哌啶的制备方法 |
CN106279074A (zh) * | 2015-05-25 | 2017-01-04 | 苏州鹏旭医药科技有限公司 | 一种化合物及其制备方法和在合成布瓦西坦中的用途 |
-
2017
- 2017-01-13 CN CN201710025130.4A patent/CN106748950B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1882535A (zh) * | 2003-09-24 | 2006-12-20 | Ucb股份有限公司 | 2-氧代-1-吡咯烷衍生物的制备方法 |
CN106279074A (zh) * | 2015-05-25 | 2017-01-04 | 苏州鹏旭医药科技有限公司 | 一种化合物及其制备方法和在合成布瓦西坦中的用途 |
CN105130879A (zh) * | 2015-07-24 | 2015-12-09 | 沧州那瑞化学科技有限公司 | (R)-3-Boc-氨基哌啶的制备方法 |
Non-Patent Citations (1)
Title |
---|
Pharmacokinetics and Metabolism of 14C-Brivaracetam, a Novel SV2A Ligand, in Healthy Subjects;Maria Laura Sargentini-Maier等;《DRUG METABOLISM AND DISPOSITION》;20081231;第36卷(第1期);第36-45页 |
Also Published As
Publication number | Publication date |
---|---|
CN106748950A (zh) | 2017-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106748950B (zh) | 一种布瓦西坦及其中间体的制备方法 | |
CN108129288B (zh) | 一种反式-3-羟基环丁基甲酸的合成方法 | |
CN110590635A (zh) | 左乙拉西坦及其中间体的制备方法 | |
AU2016232270B2 (en) | Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydro pyrimidine-5-carbonitrile | |
CN106699595B (zh) | 一种拉科酰胺制备方法 | |
CN106279175A (zh) | 一种厄他培南单钠盐的制备方法 | |
CN103044468A (zh) | N-(2-吡嗪羰基)-l-苯丙氨酸-l-亮氨酸硼酸的制备方法 | |
CN108586399A (zh) | 一种非罗考昔的合成方法 | |
CN106008316B (zh) | 一种合成雷迪帕韦手性中间体的方法 | |
CN106749071A (zh) | 一种芳香类1,2,4,5‑四嗪化合物的制备方法 | |
CN106946724B (zh) | 单胺基抑制剂类中间体2-乙酰氨基-2-苄基丙二酸单乙酯的合成方法 | |
CN109503568A (zh) | 一种达沙替尼的制备方法 | |
CN112047896B (zh) | 芳环基或芳杂环基四氮唑的合成方法 | |
CN103044467A (zh) | 一种制备用于合成硼替佐米的中间体的方法 | |
CN101743218A (zh) | 光学活性反式-2-氨基环己醇的制备方法及其中间体 | |
CN109574778A (zh) | 一种布瓦西坦及其中间体的制备方法 | |
CN107089928A (zh) | N‑Boc‑L‑炔丙基甘氨酸的合成方法 | |
CN109879775A (zh) | 一种5-氨基乙酰丙酸盐酸盐中间体的环保制备方法 | |
CN110724146B (zh) | 一种枸橼酸托法替布的制备方法 | |
CN110746371B (zh) | 制备阿瑞匹坦的中间体及其制备方法与应用 | |
CN102875460A (zh) | 一种制备索拉非尼的方法 | |
CN111747874B (zh) | 一种艾瑞昔布中间体及其制备方法和用途 | |
CN114539184A (zh) | 一种卡利拉嗪中间体的制备方法 | |
CN110835319B (zh) | 一种贝那普利中间体和贝那普利盐酸盐的合成方法 | |
CN111747873B (zh) | 一种艾瑞昔布中间体及其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200117 Address after: 644000 Luolong street, Nanxi District, Yibin City, Sichuan Province Patentee after: Yibin Nanxi Hongguang Pharmaceutical Co., Ltd Address before: 1, No. 1480, 610041 north section of Tianfu Road, Chengdu high tech Zone, Sichuan Patentee before: Chengdu beauty high Pharmaceutical Co., Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20170531 Assignee: CHENGDU MIRACLE PHARMACEUTICAL Co.,Ltd. Assignor: Yibin Nanxi Hongguang Pharmaceutical Co.,Ltd. Contract record no.: X2021510000026 Denomination of invention: The invention relates to a preparation method of buvastatin and its intermediate Granted publication date: 20190903 License type: Common License Record date: 20210722 |
|
EC01 | Cancellation of recordation of patent licensing contract | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: CHENGDU MIRACLE PHARMACEUTICAL CO.,LTD. Assignor: Yibin Nanxi Hongguang Pharmaceutical Co.,Ltd. Contract record no.: X2021510000026 Date of cancellation: 20220119 |